{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T02:40:13Z","timestamp":1718764813593},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.dsx.2016.08.006","type":"journal-article","created":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T02:18:40Z","timestamp":1472177920000},"page":"51-57","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Titration of basal insulin or immediate addition of rapid acting insulin in patients not at target using basal insulin supported oral antidiabetic treatment \u2013 A prospective observational study in 2202 patients"],"prefix":"10.1016","volume":"11","author":[{"given":"Thorsten","family":"Siegmund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Pfohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Forst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Pscherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bramlage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Foersch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Borck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Seufert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2016.08.006_bib0005","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2016.08.006_bib0010","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.dsx.2016.08.006_bib0015","first-page":"B21","article-title":"Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients","volume":"23","author":"Shichiri","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.08.006_bib0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-8227(00)00122-4","article-title":"Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study","volume":"48","author":"Wake","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl S4","key":"10.1016\/j.dsx.2016.08.006_bib0025","article-title":"American Diabetes Association Standards of medical care in diabetes\u20132015: summary of revisions","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.08.006_bib0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00125-014-3460-0","article-title":"Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach: update to a position statement of the American Diabetes Association and the European Association for the study of diabetes","volume":"58","author":"Inzucchi","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2016.08.006_bib0035","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1742-1241.2002.tb11297.x","article-title":"Insulin glargine (Lantus)","volume":"56","author":"Owens","year":"2002","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.dsx.2016.08.006_bib0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1463-1326.2008.01015.x","article-title":"Insulin analogues: an example of applied medical science","volume":"11","author":"Sheldon","year":"2009","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl. 2","key":"10.1016\/j.dsx.2016.08.006_bib0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1463-1326.2008.00841.x","article-title":"Reaching glycaemic targets while minimizing hypoglycaemia in insulin-treated type 2 diabetes patients","volume":"10","author":"Mathieu","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.dsx.2016.08.006_bib0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1464-5491.2003.00999.x","article-title":"Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patients","volume":"20","author":"Group HOESI","year":"2003","journal-title":"Diabetic Med: J Brit Diabetic Assoc"},{"key":"10.1016\/j.dsx.2016.08.006_bib0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2003-39080","article-title":"A one-year, randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with type 2 diabetes","volume":"35","author":"Massi Benedetti","year":"2003","journal-title":"Hormone Metab Res=Hormon-und Stoffwechselforschung=Hormones Metab"},{"key":"10.1016\/j.dsx.2016.08.006_bib0060","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/diacare.23.8.1130","article-title":"Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes HOE 901\/3002 study group","volume":"23","author":"Yki-Jarvinen","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.08.006_bib0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003088-200847010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of insulin glulisine","volume":"47","author":"Becker","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dsx.2016.08.006_bib0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1056\/NEJM199707173370307","article-title":"Insulin lispro","volume":"337","author":"Holleman","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2016.08.006_bib0075","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/00003088-200140090-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of insulin aspart","volume":"40","author":"Lindholm","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dsx.2016.08.006_bib0080","first-page":"279","article-title":"Insulin lispro: a fast-acting insulin analog","volume":"57","author":"Noble","year":"1998","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.dsx.2016.08.006_bib0085","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2337\/diacare.27.10.2363","article-title":"Insulin glulisine provides improved glycemic control in patients with type 2 diabetes","volume":"27","author":"Dailey","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.08.006_bib0090","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/ajhp\/56.6.542","article-title":"3rd: safety of insulin lispro: pooled data from clinical trials","volume":"56","author":"Glazer","year":"1999","journal-title":"Am J Health-Syst Pharm: AJHP"},{"key":"10.1016\/j.dsx.2016.08.006_bib0095","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1463-1326.2012.01580.x","article-title":"The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences","volume":"14","author":"Home","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.dsx.2016.08.006_bib0100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.diabet.2010.12.003","article-title":"Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review","volume":"37","author":"Rys","year":"2011","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.dsx.2016.08.006_bib0105","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1463-1326.2011.01459.x","article-title":"Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month \u2018proof-of-concept' study","volume":"13","author":"Owens","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.dsx.2016.08.006_bib0110","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1463-1326.2008.00967.x","article-title":"Orals Plus A group Ls. Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs","volume":"10","author":"Lankisch","year":"2008","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl. 2","key":"10.1016\/j.dsx.2016.08.006_bib0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1463-1326.2008.00846.x","article-title":"Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus","volume":"10","author":"Raccah","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.dsx.2016.08.006_bib0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4158\/EP10323.OR","article-title":"A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure","volume":"17","author":"Davidson","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.dsx.2016.08.006_bib0125","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4158\/EP10367.OR","article-title":"Comparison of 2 intensification regimens with rapid-acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: the step-wise randomized study","volume":"17","author":"Meneghini","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.dsx.2016.08.006_bib0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.diabet.2012.08.010","article-title":"Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: results of the OSIRIS study","volume":"38","author":"Raccah","year":"2012","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.dsx.2016.08.006_bib0135","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4093\/dmj.2012.36.3.230","article-title":"Glycemic effects of once-a-day rapid-acting insulin analogue addition on a basal insulin analogue in korean subjects with poorly controlled type 2 diabetes mellitus","volume":"36","author":"Choe","year":"2012","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.dsx.2016.08.006_bib0140","article-title":"Randomized 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections","author":"Riddle","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.dsx.2016.08.006_bib0145","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/dc12-1988","article-title":"Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial","volume":"36","author":"Umpierrez","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.08.006_bib0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/dia.2011.0163","article-title":"Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study","volume":"14","author":"Del Prato","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.dsx.2016.08.006_bib0155","doi-asserted-by":"crossref","DOI":"10.1111\/dom.12303","article-title":"Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial","author":"Tinahones","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.dsx.2016.08.006_bib0160","doi-asserted-by":"crossref","DOI":"10.2337\/dc13-2664","article-title":"AUTONOMY: The first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes","author":"Edelman","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2016.08.006_bib0165","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.clinthera.2010.05.001","volume":"32","author":"Miser","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.dsx.2016.08.006_bib0170","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1742-1241.2009.02064.x","article-title":"Intensification to biphasic insulin aspart 30\/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational study","volume":"63","author":"Gumprecht","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.dsx.2016.08.006_bib0175","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2147\/VHRM.S82720","volume":"11","author":"Pfohl","year":"2015","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.dsx.2016.08.006_bib0180","first-page":"213","article-title":"Glargine and detemir: safety and efficacy profiles of the long-acting basal insulin analogs","volume":"2","author":"Poon","year":"2010","journal-title":"Drug, Healthc Patient Saf"},{"key":"10.1016\/j.dsx.2016.08.006_bib0185","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0149-2918(03)80156-X","article-title":"Insulin glargine: a systematic review of a long-acting insulin analogue","volume":"25","author":"Wang","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.dsx.2016.08.006_bib0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3111\/13696990903485154","article-title":"Healthcare utilization changes in relation to treatment intensification with insulin aspart in patients with type 2 diabetes. Data from a large US managed-care organization","volume":"13","author":"Aagren","year":"2010","journal-title":"J Med Econ"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402116301357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402116301357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T02:14:38Z","timestamp":1718763278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402116301357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1871402116301357"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2016.08.006","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Titration of basal insulin or immediate addition of rapid acting insulin in patients not at target using basal insulin supported oral antidiabetic treatment \u2013 A prospective observational study in 2202 patients","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2016.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}